Nordlinger B, Peschaud F, Malafosse R
Department of Surgery, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France.
Colorectal Dis. 2003 Sep;5(5):515-7. doi: 10.1046/j.1463-1318.2003.00514.x.
Resection of liver metastases due to large bowel cancer has become an important part of treatment. In recent years, there have been advances in technique and the selection of patients has been extended. Surgery is the only modality which currently offers the possibility of long-term survival. Resection combined with chemotherapy may offer improved survival, but more data are needed. Chemotherapy may cause regression of metastases to permit resection where initially they were considered unresectable. The data available from such studies are presented.
切除因大肠癌导致的肝转移瘤已成为治疗的重要组成部分。近年来,技术有了进步,患者的选择范围也有所扩大。手术是目前唯一能提供长期生存可能性的治疗方式。手术联合化疗可能会提高生存率,但还需要更多数据。化疗可能会使转移瘤缩小,从而使原本被认为无法切除的转移瘤能够被切除。本文展示了此类研究的现有数据。